J. Dillner
Journal of the National Cancer Institute · 2001–2020
A researcher in the Science corpus: 10 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Whom J. Dillner trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from J. Dillner's perspective
Ordered by how strongly the researchers J. Dillner trusts endorse each paper. Same corpus, a different order for every researcher.
- ImageNet classification with deep convolutional neural networks
- Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update (International Journal of Cancer)
- Overview of the European and North American studies on HPV testing in primary cervical cancer screening (International Journal of Cancer)
- Estimates of cancer incidence and mortality in Europe in 1995. (European Journal of Cancer)
- Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. (Vaccine)
- Epidemiologic classification of human papillomavirus types associated with cervical cancer. (New England Journal of Medicine)
- HPV screening for cervical cancer in rural India. (New England Journal of Medicine)
- Deep learning for computational biology
- Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. (Journal of the National Cancer Institute. Monographs)
- Nonparametric Estimation from Incomplete Observations
Their papers
- ViraMiner: Deep learning on raw DNA sequences for identifying viral genomes in human samples (2019) — 111 citations
- HPV Vaccination and the Risk of Invasive Cervical Cancer. (2020) — 1,084 citations
- Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. (2014) — 1,597 citations
- Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. (2010) — 638 citations
- Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women of 30 years and older (2009) — 684 citations
- Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer (2008) — 704 citations
- Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study (2008) — 684 citations
- Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. (2008) — 673 citations
- Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions (2007) — 1,759 citations
- Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine. (2001) — 653 citations